Peter Carmeliet
Peter Carmeliet
hoogleraar, Universiteit van Leuven, VIB
Verified email at kuleuven.vib.be
TitleCited byYear
Angiogenesis in cancer and other diseases
P Carmeliet, RK Jain
nature 407 (6801), 249, 2000
90532000
Mechanisms of angiogenesis and arteriogenesis
P Carmeliet
Nature medicine 6 (4), 389, 2000
46292000
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
P Carmeliet, V Ferreira, G Breier, S Pollefeyt, L Kieckens, M Gertsenstein, ...
Nature 380 (6573), 435, 1996
45331996
Angiogenesis in health and disease
P Carmeliet
Nature medicine 9 (6), 653, 2003
43102003
Angiogenesis in life, disease and medicine
P Carmeliet
Nature 438 (7070), 932, 2005
33992005
Molecular mechanisms and clinical applications of angiogenesis
P Carmeliet, RK Jain
Nature 473 (7347), 298, 2011
32362011
Overexpression of hypoxia-inducible factor 1α in common human cancers and their metastases
H Zhong, AM De Marzo, E Laughner, M Lim, DA Hilton, D Zagzag, ...
Cancer research 59 (22), 5830-5835, 1999
30361999
Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
P Carmeliet, Y Dor, JM Herbert, D Fukumura, K Brusselmans, ...
Nature 394 (6692), 485, 1998
27351998
Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
P Carmeliet, L Moons, A Luttun, V Vincenti, V Compernolle, M De Mol, ...
Nature medicine 7 (5), 575, 2001
17342001
Basic and therapeutic aspects of angiogenesis
M Potente, H Gerhardt, P Carmeliet
Cell 146 (6), 873-887, 2011
15332011
Targeted Deficiency or Cytosolic Truncation of the VE-cadherin Gene in Mice Impairs VEGF-Mediated Endothelial Survival and Angiogenesis
P Carmeliet, MG Lampugnani, L Moons, F Breviario, V Compernolle, ...
Cell 98 (2), 147-157, 1999
13391999
uPAR: a versatile signalling orchestrator
F Blasi, P Carmeliet
Nature reviews Molecular cell biology 3 (12), 932, 2002
12902002
Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1
A Luttun, M Tjwa, L Moons, Y Wu, A Angelillo-Scherrer, F Liao, JA Nagy, ...
Nature medicine 8 (8), 831, 2002
12132002
Hypoxia and inflammation
HK Eltzschig, P Carmeliet
New England Journal of Medicine 364 (7), 656-665, 2011
11482011
Physiological consequences of loss of plasminogen activator gene function in mice
P Carmeliet, L Schoonjans, L Kieckens, B Ream, J Degen, R Bronson, ...
Nature 368 (6470), 419, 1994
11361994
Molecular mechanisms of blood vessel growth
EM Conway, D Collen, P Carmeliet
Cardiovascular research 49 (3), 507-521, 2001
10842001
Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
B Oosthuyse, L Moons, E Storkebaum, H Beck, D Nuyens, K Brusselmans, ...
Nature genetics 28 (2), 131, 2001
10702001
VEGF as a key mediator of angiogenesis in cancer
P Carmeliet
Oncology 69 (Suppl. 3), 4-10, 2005
10362005
Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
P Carmeliet, RK Jain
Nature reviews Drug discovery 10 (6), 417, 2011
9882011
VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death
D Lambrechts, E Storkebaum, M Morimoto, J Del-Favero, F Desmet, ...
Nature genetics 34 (4), 383, 2003
9412003
The system can't perform the operation now. Try again later.
Articles 1–20